ABCG1 and type 2 diabetes mellitus: Proprotein convertase subtilisin/kexin type 9 inhibitors improve HDL CEC mediated by ABCG1 and aqueous diffusion in patients with familial hypercholesterolemia [204], but no data exist specifically in T2DM or obesity to our knowledge.